Shubham Shrivastava et al., 2021, maintain that elevated levels of neutrophil-activated proteins such as DEFA1 alpha-defensins, calprotectin S100A8/A9, and MPO myeloperoxidase are associated with disease severity in patients with COVID-19 [163]. This evidence concerns the gene MPO and COVID-19.